找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiotherapy in Managing Brain Metastases; A Case-Based Approac Yoshiya Yamada,Eric Chang,Jonathan Knisely Book 2020 Springer Nature Switze

[復(fù)制鏈接]
樓主: coherent
21#
發(fā)表于 2025-3-25 03:28:49 | 只看該作者
Introduction,The development of stereotactic radiosurgery for the treatment of brain metastases has been an evolution of improvements in technology coupled with paradigm shifts in oncology, providing a highly effective therapy for an otherwise clinically vexing problem. The historical development of this seminal medical innovation is described.
22#
發(fā)表于 2025-3-25 08:36:11 | 只看該作者
23#
發(fā)表于 2025-3-25 12:15:08 | 只看該作者
24#
發(fā)表于 2025-3-25 18:25:50 | 只看該作者
25#
發(fā)表于 2025-3-25 21:52:00 | 只看該作者
26#
發(fā)表于 2025-3-26 00:18:53 | 只看該作者
978-3-030-43742-8Springer Nature Switzerland AG 2020
27#
發(fā)表于 2025-3-26 06:14:28 | 只看該作者
Supportive Medical Management of Brain Metastases Patients Including Treatment Complicationsent. These include focal neurologic deficits, seizures, cognitive impairment, and headache. We will review the data regarding the management of these problems. Iatrogenic sequelae and radiotherapy-related complications such as radiation necrosis will also be specifically addressed.
28#
發(fā)表于 2025-3-26 10:12:19 | 只看該作者
Radiobiology of Stereotactic Radiosurgerynized that the immune system, which plays key roles in tumor surveillance and suppression, is an integral component of the SRS response. In addition to the hypothesis that SBRT may be able to overcome tumor-induced immunosuppression, there is tremendous excitement that SBRT could act synergistically
29#
發(fā)表于 2025-3-26 15:17:38 | 只看該作者
Indications for Whole-Brain Radiation Therapyive to WBRT in patients with 4–15 metastases, though the results of randomized trials are awaited. Newer systemic therapies such as targeted therapy and immunotherapy have demonstrated relatively high rates of intracranial response for patients with limited intracranial disease, though the optimal s
30#
發(fā)表于 2025-3-26 18:22:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-11-1 05:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
贺兰县| 札达县| 石首市| 谷城县| 思南县| 永泰县| 安化县| 朝阳县| 天峻县| 呼伦贝尔市| 山东省| 宜良县| 石景山区| 姜堰市| 金华市| 双鸭山市| 浦县| 茂名市| 塔河县| 商都县| 土默特左旗| 武宣县| 青州市| 谢通门县| 安新县| 桓仁| 吴忠市| 分宜县| 古田县| 子洲县| 通山县| 常山县| 韶山市| 曲麻莱县| 淄博市| 甘肃省| 乌审旗| 永春县| 咸宁市| 永登县| 富宁县|